Recursion Alternatives & Competitors
12 companies similar to Recursion — Decoding Biology to Radically Improve Lives
Companies similar to Recursion
AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
Verge Labs
Better drugs, faster. For patients who can’t wait.
Cellarity
Rewriting the rules of drug creation
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Rival Readout
Competing with Recursion? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Dewpoint Therapeutics
Translating condensate biology into medicine.
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Ipsen
Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Pannex Therapeutics Inc.
We are the Pannexin people.
ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intract...
About Recursion
Recursion (NASDAQ: RXRX) is at the forefront of the TechBio sector, leveraging its platform, Recursion OS, to harness advanced AI and machine learning in pursuit of transforming medicine. Founded in 2013 and headquartered in the United States, Recursion is ambitiously decoding biology with the aim of radically improvin...
AI-based drug discovery and development, Clinical trial management and execution, Partnerships for drug research and development, Data-driven insights and analytics for drug discovery
Pharmaceutical companies, Biotech firms, Healthcare institutions, Life sciences researchers, Oncology specialists
TechBio, Decoding Biology, Recursion OS, Drug Discovery, Biological And Chemical Datasets, Phenomics, Clinical-stage Biotechnology, Drug Repurposing, Immuno-oncology, Diseases Of Aging, Supercomputing
B2B, Platform, SaaS
Licensing, Subscription, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Recursion: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Recursion on 23 Sep 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.